Innospec (IOSP, Specialty chemical makers) Stock Valuation & Fair Value
Mixed on our testsInnospec (IOSP, Specialty chemical makers) trades at a current P/E of 15.5, about 6% above its historical normal valuation, with a forward growth estimate of 16.8% and a PEG of 0.92. Analysts' one-year estimates have been hit 27% of the time. Priced at its historical normal P/E of 14.7 on the same blended earnings, the 2026-11-06 close of $78.21 corresponds to about $74.10 a share. This is a valuation reference, not a price target.
How to read these numbers: the PEG ratio and current P/E versus normal P/E.
- Price $78.21 at the Nov 6 close, 18.3% below the 20-day average ($95.78) and 17.9% below the 50-day ($95.30).
- RSI (14) at 17.6.
- 52-week range $65.12 to $101.41: the price is 22.9% below the high and 20.1% above the low.
The Street vs SeerForecast
Wall Street's mean price target for IOSP is $101.00 across 3 analysts, 29.1% above the current price. Our SeerForecast read of the same stock, formed without analyst targets: mixed on our tests. When the two disagree, start your digging there.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating moved from mixed on our tests (2026-07-31) to trading above its usual valuation (2026-11-02).
Not every point was recorded live. Points marked recalculated are worked out from the metrics tickerseer archived that week.
Selected weeks: the first, the latest, every week the rating moved, and the cheapest and dearest.
Show all 29 readings
Frequently asked questions
Is Innospec stock overvalued?
At a current P/E of 15.5 versus its historical normal P/E of 14.7, Innospec trades about 6% above its typical valuation, with a PEG of 0.92 on 16.8% forward growth. tickerseer currently rates it mixed on our tests.
What is Innospec's fair value and PEG?
Innospec trades at a current P/E of 15.5 against a historical normal P/E of 14.7, a PEG of 0.92, and a forward growth estimate of 16.8%. Priced at its historical normal P/E of 14.7 on the same blended earnings, the 2026-11-06 close of $78.21 corresponds to about $74.10 a share. This is a valuation reference, not a price target.
Has tickerseer's rating of Innospec changed?
tickerseer's rating moved from mixed on our tests (2026-07-31) to trading above its usual valuation (2026-11-02).
What is the analyst price target for Innospec?
The mean Wall Street price target for Innospec is $101.00 across 3 analysts, 29.1% above the current price. tickerseer's SeerForecast verdict is formed independently of analyst targets.
Industry: Specialty chemical makers. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and an AI research note where we have one. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. We also send a short product update once a month. Educational content, not investment advice.